IL1B and cancer: A study by Kolb et al proved that increased activation of the inflammatory markers NLRC4 and IL-1b lead to a rise in ANGPTL4 secretion in primary adipocytes [61] showing a possible mechanism through which inflammation-mediated secretion of ANGPTL4 could lead to the progression of cancer.